Live Oak Acquisition Corp V

LOKV

Market cap $301M

NEW YORK--(BUSINESS WIRE)--Teamshares (the “Company”), a tech-enabled acquiror of SMEs and Live Oak Acquisition Corp. V (NASDAQ: LOKV, “Live Oak V”), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and Exchange Commission of their joint registration statement on Form S-4 (the “Registration Statement”) in connection with their proposed business combination. The Registration Statement includes a preliminary proxy statement/prospectus and.

NEW YORK--(BUSINESS WIRE)--Teamshares (the “Company”), a tech-enabled acquiror of SMEs, announced it will host an investor day for institutional investors and equity research analysts on March 31, 2026 at the Nasdaq MarketSite®. The event will demonstrate continued progress on the Company's plan to become publicly traded via a proposed business combination with Live Oak Acquisition Corp. V (NASDAQ: LOKV), with a $126 million common equity PIPE anchored by accounts advised by T. Rowe Price Inves.

NEW YORK--(BUSINESS WIRE)--Teamshares Inc. (“Teamshares” or the “Company”), a tech-enabled acquiror of high-quality small-to-medium enterprises, provided a business update reflecting continued growth momentum and increasing scale as the Company moves towards an anticipated Nasdaq listing in the second quarter of 2026 via business combination with Live Oak Acquisition Corp. V (NASDAQ:LOKV) (the “Business Combination”): Teamshares completed four acquisitions from retiring owners in the fourth qua.

NEW YORK--(BUSINESS WIRE)--Teamshares Inc. (“Teamshares”), a tech-enabled acquiror of high-quality businesses, and Live Oak Acquisition Corp. V (NASDAQ: LOKV, “Live Oak V”), a publicly traded special purpose acquisition company, announced the confidential submission of a draft registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”) today in connection with a proposed business combination between Teamshares and Live Oak V announced on November 14, 2025. Upon closin.